Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Tysabri Continues Comeback; On Pace To Reach 100,000 Patients In 2010

Jul 22 2008

Related Content

FDA Gives Firms With RiskMAP Drugs 6 Months To Submit Strategy Proposals

Mar 26 2008

Genentech/Roche: The End Of An Era

Jul 21 2008

Tysabri Clears FDA For Moderate To Severe Crohn’s Disease

Jan 14 2008

Biogen Hikes Guidance On Solid Quarter

Apr 23 2008

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window